These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 3002972)
1. Direct activation of Sendai virus (HVJ)-specific cell-mediated immunity of mice for second set rejection of the virus-infected syngeneic tumor by noninfectious virus-sensitized spleen cells. Kamihira O; Nakashima I; Hasegawa T; Ando K; Isobe K; Nagase F; Hasegawa Y; Yoshida T; Kawashima K; Yoshida T Immunol Lett; 1985; 11(2):75-81. PubMed ID: 3002972 [TBL] [Abstract][Full Text] [Related]
2. Induction of tumor resistance in mice by L1210 leukemia cells persistently infected with HVJ (Sendai virus). Takeyama H; Kawashima K; Yamada K; Ito Y Gan; 1979 Aug; 70(4):493-501. PubMed ID: 229053 [TBL] [Abstract][Full Text] [Related]
3. A significant role of proximity of HVJ-antigen in the generation of tumor immunity. Kawashima K; Watanabe E; Kato Y; Suzuki H; Minami S; Isobe K; Ogura M; Nagura E; Yamada K Gan; 1981 Dec; 72(6):955-8. PubMed ID: 6281118 [TBL] [Abstract][Full Text] [Related]
4. Aerosol vaccination with a sendai virus temperature-sensitive mutant (HVJ-pB) derived from persistently infected cells. Iwata H; Tagaya M; Matsumoto K; Miyadai T; Yokochi T; Kimura Y J Infect Dis; 1990 Aug; 162(2):402-7. PubMed ID: 1695654 [TBL] [Abstract][Full Text] [Related]
5. Curing of virus persistent infection in HVJ (sendai virus) carrier hamster tumor cells by transplantation. Ogura H; Sato H; Hatano M Gan; 1981 Aug; 72(4):498-503. PubMed ID: 6273248 [TBL] [Abstract][Full Text] [Related]
6. Relationship between tumor formation and cell-mediated immunity in hamsters with transplanted HVJ (Sendai virus)-carrying tumor cells. Ogura H; Sato H; Tanaka J; Hatano M; Fukuda S; Morita O Gan; 1980 Jun; 71(3):325-32. PubMed ID: 6252084 [TBL] [Abstract][Full Text] [Related]
7. Immunity to virus-free syngeneic tumor cell transplantation in the BALB/c mouse after immunization with homologous tumor cells infected with type C virus. Al-Ghazzouli IK; Donahoe RM; Huang KY; Sass B; Peters RL; Kelloff GJ J Immunol; 1976 Dec; 117(6):2239-48. PubMed ID: 186539 [TBL] [Abstract][Full Text] [Related]
8. In vitro curing of persistent infection of HVJ (sendai virus) carrier tumor cells by spleen cells. Ogura H; Sato H; Hatano M Gan; 1981 Aug; 72(4):504-11. PubMed ID: 6171472 [TBL] [Abstract][Full Text] [Related]
9. The use of allogeneic stimulation and exogenous interleukin for syngeneic tumor rejection. Sherburne CG; Condie RM; Nnadi EC; Adlin M Transplant Proc; 1987 Feb; 19(1 Pt 1):628-31. PubMed ID: 3493564 [TBL] [Abstract][Full Text] [Related]
10. Immune reactivity of allogeneically pregnant mice to paternal MHC antigens on fetal and placental cells assessed by second set rejection of ascites tumor cells. Saito M; Nakashima I; Mizoguchi K; Isobe K; Nagase F; Goto S; Tomoda Y J Reprod Immunol; 1985 Nov; 8(2-3):139-51. PubMed ID: 4093908 [TBL] [Abstract][Full Text] [Related]
11. Cooperation between humoral factor(s) and Lyt-2+ T cells in effective clearance of Sendai virus from infected mouse lungs. Iwai H; Yamamoto S; Otsuka Y; Ueda K Microbiol Immunol; 1989; 33(11):915-27. PubMed ID: 2574407 [TBL] [Abstract][Full Text] [Related]
12. Common leukemia-associated antigen of DBA/2 mouse leukemia detected by tumor rejection and complement-dependent cytotoxicity assays. Kawashima K; Takeyama H; Takahashi T; Kato Y; Watanabe E; Suzuki H; Minam S; Isobe K; Yamada K; Ito Y Gan; 1979 Dec; 70(6):769-76. PubMed ID: 94022 [TBL] [Abstract][Full Text] [Related]
13. Involvement of fusion activity of ultraviolet light-inactivated Sendai virus in formation of target antigens recognized by cytotoxic T cells. Sugamura K; Shimizu K; Bach FH J Exp Med; 1978 Jul; 148(1):276-87. PubMed ID: 78960 [TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immunity to Sendai virus infection in mice. Anderson MJ; Bainbridge DR; Pattison JR; Heath RB Infect Immun; 1977 Jan; 15(1):239-44. PubMed ID: 188766 [TBL] [Abstract][Full Text] [Related]
15. Joint recognition by cytotoxic T cells of inactivated Sendai virus and products of the major histocompatibility complex. Schrader JW; Edelman GM J Exp Med; 1977 Mar; 145(3):523-39. PubMed ID: 233918 [TBL] [Abstract][Full Text] [Related]
16. Immediate protection of mice from lethal wild-type Sendai virus (HVJ) infections by a temperature-sensitive mutant, HVJpi, possessing homologous interfering capacity. Kiyotani K; Takao S; Sakaguchi T; Yoshida T Virology; 1990 Jul; 177(1):65-74. PubMed ID: 2162116 [TBL] [Abstract][Full Text] [Related]
17. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors. Fortner GW; Kripke ML J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296 [TBL] [Abstract][Full Text] [Related]
18. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response. Gordon WC; Prager MD Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275 [TBL] [Abstract][Full Text] [Related]
19. High-grade tumor-specific immunity induced by L1210 leukemia variants obtained from the culture of L1210 cells fused with Lesch-Nyhan fibroblasts. Kawashima K; Nagura E; Watanabe E; Mizoguchi K; Saga S; Isobe K; Nakashima I; Yamada K; Oikawa T; Kojima K Int J Cancer; 1983 Oct; 32(4):507-14. PubMed ID: 6618710 [TBL] [Abstract][Full Text] [Related]
20. Protection of mice against virulent virus infection by a temperature-sensitive mutant derived from an HVJ (Sendai virus) carrier culture. Kimura Y; Aoki H; Shimokata K; Ito Y; Takano M; Hirabayashi N; Norrby E Arch Virol; 1979; 61(4):297-304. PubMed ID: 229796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]